During the past decade, Fakultna nemocnica Trencin conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fakultna nemocnica Trencin" #1 sponsor was "Kodiak Sciences Inc" with 2 trials, followed by "Oxurion" with 2 trials sponsored, "Alvotech Swiss AG" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "Brno University Hospital" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fakultna nemocnica Trencin" #1 collaborator was "Epidemiological and Clinical Research Information Network" with 1 trials as a collaborator, "Harmonium International Inc." with 1 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator, "Pharma Agency" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Fakultna nemocnica Trencin" are "Diabetic Retinopathy" (3 trials), "Diabetes Mellitus" (2 trials), "Macular Edema" (2 trials), "Acute Coronary Syndrome" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Fakultna nemocnica Trencin" in a lesser frequency.

Most popular intervention types in "Fakultna nemocnica Trencin" are "Drug" (13 trials), "Other" (4 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Aflibercept" (2 trials), "KSI-301" (2 trials), "Sham Procedure" (2 trials) and "AVT06 (proposed aflibercept biosimilar)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fakultna nemocnica Trencin" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Fakultna nemocnica Trencin". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Fakultna nemocnica Trencin, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Fakultna nemocnica Trencin, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Fakultna nemocnica Trencin has several departments that took part in Clinical trials: "Fakultna nemocnica Trencín; Onkologicke odd." - 3 trials